Polymorphisms of β1-Adrenoreceptor Gene and Cardiovascular Complications in Patients with Thyrotoxicosis

Table 2

Genotype and allele distribution for Gly389Arg polymorphism in patients with Graves’ disease and control group.

Genotype		Number of subjects, 𝑛	%	Allele frequency
Graves’ disease group 165
Group 1	GG (Glu389Glu)	9	5.4	A—0.66; G—0.34*
Group 2	CG (Glu389Arg)	94	57
Group 3	CC (Arg389Arg)	62	37.6
Control group 101	GG (Glu389Glu)	8	8	A—0.74; G—0.26
	CG (Glu389Arg)	37	37
	CC (Arg389Arg)	56	55

^∗𝑃=0.01 Graves’ disease group versus control group.